ARF Flashcards

1
Q

Respiratory Failure:

A clinical condition in which the _____ system fails to maintain _______.

A

pulmonary system

adequate gas exchange

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Respiratory Failure:

Failure to meet _____, ______, or _____ demand of the patient.

A

Oxygenation,

Ventilation,

Metabolic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Deficiency in the performance of the pulmonary system usually occurs ____ to another disorder that has ____ the normal function of the pulmonary system.

A

secondary,

altered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the causes of respiratory failure?

  1. ____
  2. _____
  3. _____
A
  1. Depressed ventilatory drive
  2. Failing ventilatory pump
  3. Gas Exchange organ

Any combination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Respiratory failure can be __

a. Acute
b. Chronic
c. acute-on-chronic
d. All of the above

A

d. all of the above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Whane PaO2 is lower than 8.0 kPa and PaCO2 is normal this is…

A

Type 1 Respiratory failure (oxygenation failiure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When PaO2 is lower than 8.0 kPa and PaCO2 is higher than 6.5 kPa this is….

A

Type 2 Respiratory failure (ventilation failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Type 1 Respiratory failure is classified as…
PaO2 is ____ than 8.0 kPa
PaCO2 is ______ than 6.5kPa

A

lower

normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Type 2 Respiratory failure is classified as…
PaO2 is ____ than 8.0 kPa
PaCO2 is ______ than 6.5kPa

A

lower

higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Normal value of PaO2?

A

12-15 kPa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Normal value of PaCO2?

A

4.5-5.5 kPa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Normal value of pH

A

7.35 - 7.45
higher =alkalotic
lower = acidotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Type 1 respiratory failure is caused by diseases that damage ______

A

the lung tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Type 1 respiratory failure is caused by impaired gas diffusion across _______ membrane

A

alveolar capillary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pulmonary diseases that can lead to type 1 respiratory failure are…?

A

Asthma
Pneumonia
Effusion
COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Vascular diseases that can lead to type 1 respiratory failure are…?

A

Pulmonary embolism
Cardiogenic pulmonary
Oedema
CCF (congestive cardiac failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is V/Q ratio?

A

Ventilation/perfusion

18
Q

What is considered a normal V/Q ratio?

A

0.8

19
Q

Pathphysiologcal processes involved in Acute Resp Failure are:
A_____ H____
V_____ and P_____ mismatch
D______ impairment

A

Alveolar Hypoventilation
Ventilation and Perfusion mismatch
Diffusion impairment

20
Q
PROGRESSION OF HYPOXAEMIA
1. 
2.
3.
4.
A
  1. low O2 at cellular level
  2. tissue hypoxia (impaired perfusion)
  3. Lactic acidosis
  4. multiple organ dysfunction
21
Q

MECHANISMS UNDERLYING AIRFLOW LIMITATIONS IN COPD

Small Airways disease:
1.
2.
3.

Parenchymal Destruction
1.
2.

A

Small Airways disease:

  1. Airway inflammation
  2. Mucus retention
  3. Increased Airway Resistance

Parenchymal Destruction

  1. Loss of alveolar attachment
  2. Decrease in elastic recoil
22
Q
Risk factors for COPD
Mitigatable:
C\_\_\_\_\_
O\_\_\_\_\_
E\_\_\_\_\_
I\_\_\_\_\_\_
A

Cigarette smoke
Occupational dust and chemicals
Enviromental smoke/tobacco
Indoor and outdoor air pollution

23
Q
Risk factors for COPD
Un-Mitigatable:
G\_\_\_\_\_
I\_\_\_\_\_
S\_\_\_\_ E\_\_\_\_
A\_\_\_\_\_\_
A

Genes
Infections
Socio-economic status
Aging population

24
Q
Diagnosis of COPD
Symptoms:
S\_\_\_\_\_\_
C\_\_\_\_\_\_ C\_\_\_\_\_
S\_\_\_\_
PLUS
Risk Factors:
T\_\_\_\_\_
O\_\_\_\_\_
I\_\_\_\_\_

Tested by S______

A
Diagnosis of COPD
Symptoms:
Short of breath
Chronic Cough
Sputum production
PLUS
Risk Factors:
Tabacco
Occupation
Indoor/outdoor pollution

Tested by Spirometry

25
Q

Exasperation of COPD:

Increased d______.
Increased cough; increased sputum purulence and increased sputum v______.
U_____ a____ symptoms (eg, colds and sore throats).
Increased wheeze and chest tightness.
Malaise.
Reduced exercise tolerance.
Increased f______.
Marked respiratory distress with dyspnoea and tachypnoea, acute c_______, increased c_____, peripheral o______.
Respiratory failure - may develop and may require non-invasive ventilation (NIV)

A

Exasperation of COPD:

Increased dyspnoea.
Increased cough; increased sputum purulence and increased sputum volume.
Upper airway symptoms (eg, colds and sore throats).
Increased wheeze and chest tightness.
Malaise.
Reduced exercise tolerance.
Increased fatigue.
Marked respiratory distress with dyspnoea and tachypnoea, acute confusion, increased cyanosis, peripheral oedema.
Respiratory failure - may develop and may require non-invasive ventilation (NIV)

26
Q
NICE Guideline treatment of COPD
A\_\_\_\_\_\_\_
O\_\_\_\_\_\_\_
P\_\_\_\_\_\_\_
N\_\_\_\_\_\_\_ B\_\_\_\_\_\_
IV T\_\_\_\_\_\_\_\_\_\_\_
NIV (Non-I\_\_\_\_\_ V\_\_\_\_\_\_)
A
NICE Guideline treatment of COPD
Antibiotics
Oxygen therapy
Physiotherapy
Nebulised Bronchodilators
IV theophyline
NIV (Non-Invasive Ventilation)
27
Q
DIFFERENTIAL
COPD vs. Asthma
Age:
Symptom progression:
History:
A

COPD:
Onset in later life
Symptoms slowly progressive
Long smoking history

ASTHMA
Onset early in life
Symptoms vary day to day
Symptoms worse at night/morning
Allergy, rhinitis, and/or eczema
Family history of Asthma
28
Q

Asthma definition:
Chronic ______ disorder of the _______.

Airflow ________ and increased resistance

___________, airway oedema and mucus production Air trapping, prolong exhalation, V/Q mismatch, shunt

A

Asthma definition:
Chronic inflammatory disorder of the airway.

Airflow obstruction and increased resistance

Bronchoconstriction, airway oedema and mucus production Air trapping, prolong exhalation, V/Q mismatch, shunt

29
Q

Signs and Symptoms:

W\_\_\_\_\_
C\_\_\_\_\_ t\_\_\_\_\_
Unable to talk in full sentences
H\_\_\_\_\_ – \_\_\_\_\_\_ SpO2
C\_\_\_\_\_
Hyperventilating
Dyspnoea – SoB
Peak airway flow is < \_\_%
A

Signs and Symptoms:

Wheezy
Chest tightness
Unable to talk in full sentences
Hypoxic – decreased SpO2
Cough
Hyperventilating
Dyspnoea – SoB
Peak airway flow is < 75%
30
Q

Moderate Asthma:
Increasing ____
PEF ________
No features of ______

A

Moderate Asthma:
Increasing symptoms
PEF >50-75% best or predicted
No features of acute severe asthma

31
Q
Severe Asthma:
One of -
PEF \_\_\_\_ best or predicted
RR greater than\_\_\_\_\_ and HR greater than \_\_\_\_
Inability to complete \_\_\_\_\_\_\_
A

Severe Asthma:
One of -
PEF 33-50% best or predicted
RR greater than 25/min and HR greater than 110/min
Inability to complete sentences in one breath

32
Q
Life-threatening Asthma
Severe asthma plus one of -
PEF less than \_\_\_\_
SPO2 less than \_\_\_\_\_
PaO2 less than \_\_\_\_\_kPa
S\_\_\_\_\_ c\_\_\_\_\_
C\_\_\_\_\_\_
poor \_\_\_\_\_\_\_ effort
A\_\_\_\_\_\_\_
Exhaustion/ altered conscious level
A
Life-threatening Asthma
Severe asthma plus one of -
PEF less than 33%
SPO2 less than 92%
PaO2 less than 8kPa
Silent chest
Cyanosis
poor respiratory effort
Arrhythmia
Exhaustion/ altered conscious level
33
Q

Near-fatal Asthma

Raised _______ and/or requiring _____ _____ with raised inflation pressures

A

Near-fatal Asthma

Raised PaCO2 and/or requiring mechanical ventilation with raised inflation pressures

34
Q

‘Pneumonia is an I_____ of the lung tissue. When a person has pneumonia the a____ s____ in their lungs become filled with m_______, f_____ and i______ cells

A

‘Pneumonia is an infection of the lung tissue. When a person has pneumonia the air sacs in their lungs become filled with microorganisms, fluid and inflammatory cells

35
Q

Signs and symptoms of Pneumonia:

T\_\_\_\_\_
C\_\_\_\_\_
S\_\_\_\_\_ 
W\_\_\_\_\_  normal range 4.0-11.0
Spo2 < maybe – 
History/risk factors
?Sepsis
A

Signs and symptoms of Pneumonia:

Temperature
Cough
Sputum 
WCC normal range 4.0-11.0
Spo2
36
Q

ABCDE Assessment
Acute Respiratory Failure
Airway

A

Airway:
Look for signs of airway obstruction,
Treat as medical emergency if obstructed
Give high flow oxygen (15l non-rebreather)
Tgt O2 = 94-98% , 88 -92% at risk of hypercapnea (COPD)
(Resus, 2019)

37
Q

ABCDE Assessment
Acute Respiratory Failure
Breathing

During the immediate assessment of breathing, it is vital to diagnose and treat immediately life-threatening conditions (e.g. acute severe asthma, pulmonary oedema, tension pneumo thorax, and massive haemothorax).

A

Breathing:

Look listen feel for signs of respiratory distress.
Count respiratory rate (12-20 is normal)
Assess depth, rhythm and symmetry
Look for chest deformity - raised Jugular venous pulse (JVP)
Record inspired oxygen concentration and monitor SpO2
Listen to the patient’s breath sounds a short distance from face
Percuss chest (hyper resonance or dullness)
Auscultate the chest
Check tracheal position
Feel the chest wall to detect surgical emphysema or crepitus

38
Q

Respiratory distress is:

s______, central cy_____, use of the a_____ muscles of respiration, and a_______ breathing.

A

Respiratory distress is:

sweating, central cyanosis, use of the accessory muscles of respiration, and abdominal breathing.

39
Q

Breath sounds
Rattling airway noises indicate the presence of airway s_____, usually caused by the inability of the patient to cough sufficiently or to take a deep breath.

S_____ or w____ suggests partial, but significant, airway obstruction.

A

Breathing sounds
Rattling airway noises indicate the presence of airway secretions, usually caused by the inability of the patient to cough sufficiently or to take a deep breath. Stridor or wheeze suggests partial, but significant, airway obstruction.

40
Q

Breathing:
Breathing Assessment:

L_____ L____ F____ for signs of respiratory distress.
Count respiratory rate (__-__ is normal)
Assess d____, r___ and s_____
Look for chest d_____ - raised J____ _____ ____ (JVP)
Record inspired oxygen concentration and monitor SpO2
Listen to the patient’s breath sounds a short distance from face
Percuss chest (hyper r_______ or dullness)
Auscultate the chest
Check t_____ position
Feel the chest wall to detect surgical e_____ or crepitus

A

Breathing:
Breathing Assessment:

Look listen feel for signs of respiratory distress.
Count respiratory rate (12-20 is normal)
Assess depth, rhythm and symmetry
Look for chest deformity - raised Jugular venous pulse (JVP)
Record inspired oxygen concentration and monitor SpO2
Listen to the patient’s breath sounds a short distance from face
Percuss chest (hyper resonance or dullness)
Auscultate the chest
Check tracheal position
Feel the chest wall to detect surgical emphysema or crepitus
Consider NIV (non-invasive ventilation)

41
Q

The specific treatment of respiratory disorders depends upon the cause. Nevertheless, all critically ill patients should be given o______. In a subgroup of patients with COPD, high concentrations of oxygen may depress breathing (i.e. they are at risk of h______ respiratory failure - often referred to as type 2 respiratory failure). Nevertheless, these patients will also sustain end-organ damage or cardiac arrest if their _______ _____ tensions are allowed to decrease. In this group, aim for a lower than normal PaO2 and oxygen saturation. Give oxygen via a V_____ 28% mask (_ L min-1) or a 24% Venturi mask (4 L min-1) initially and reassess. Aim for target SpO2 range of 88–92% in most COPD patients, but evaluate the target for each patient based on the patient’s a____ b____ g___ measurements during previous exacerbations (if available). Some patients with chronic lung disease carry an oxygen alert card (that documents their target saturation) and their own appropriate Venturi mask.

A

The specific treatment of respiratory disorders depends upon the cause. Nevertheless, all critically ill patients should be given oxygen. In a subgroup of patients with COPD, high concentrations of oxygen may depress breathing (i.e. they are at risk of hypercapnic respiratory failure - often referred to as type 2 respiratory failure). Nevertheless, these patients will also sustain end-organ damage or cardiac arrest if their blood oxygen tensions are allowed to decrease. In this group, aim for a lower than normal PaO2 and oxygen saturation. Give oxygen via a Venturi 28% mask (4 L min-1) or a 24% Venturi mask (4 L min-1) initially and reassess. Aim for target SpO2 range of 88–92% in most COPD patients, but evaluate the target for each patient based on the patient’s arterial blood gas measurements during previous exacerbations (if available). Some patients with chronic lung disease carry an oxygen alert card (that documents their target saturation) and their own appropriate Venturi mask.